SCHEMBL2460684

SCHEMBL2460684

CC(C)NC(=O)CNC(=O)c1cc(N2CCCN[C@H](C(C)C)C2)ccc1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP25 Q9UHP3 2/20 0.39
USP28 Q96RU2 1/20 0.39
IP6K1 Q92551 1/20 0.38
HDAC1 Q13547 1/20 0.37
CCR2 P41597 11/20 0.37
PSMB11 A5LHX3 1/20 0.35
PSMA7 O14818 1/20 0.35
PSMB1 P20618 1/20 0.35
PSMA1 P25786 1/20 0.35
PSMA2 P25787 1/20 0.35
PSMA3 P25788 1/20 0.35
PSMA4 P25789 1/20 0.35
PSMB8 P28062 1/20 0.35
PSMB9 P28065 1/20 0.35
PSMA5 P28066 1/20 0.35
PSMB4 P28070 1/20 0.35
PSMB6 P28072 1/20 0.35
PSMB5 P28074 1/20 0.35
PSMB10 P40306 1/20 0.35
PSMB3 P49720 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2462788 1.00 USP25 (0.39) USP25USP28IP6K1HDAC1CCR2
SCHEMBL3451783 0.95 USP25 (0.43) USP25USP28IP6K1HDAC1CCR2
SCHEMBL2458809 0.95 USP25 (0.43) USP25USP28IP6K1HDAC1CCR2
SCHEMBL2458801 0.95 USP25 (0.43) USP25USP28IP6K1HDAC1CCR2
SCHEMBL2458975 0.88 IP6K1 (0.38) IP6K1CCR2PSMB11PSMA7PSMB1
SCHEMBL2463353 0.86 IP6K1 (0.36) IP6K1CCR2
SCHEMBL2465258 0.86 USP25 (0.38) USP25USP28IP6K1HDAC1CCR2
SCHEMBL2463515 0.86 MAPT (0.41) USP25USP28IP6K1HDAC1CCR2
SCHEMBL2459768 0.86 MAPT (0.41) USP25USP28IP6K1HDAC1CCR2
SCHEMBL2459776 0.86 MAPT (0.41) USP25USP28IP6K1HDAC1CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069315-B1 QUINAZOLINONE AND ISOQUINOLINONE ACETAMIDE DERIVATIVES ORGANON NV (NL) 2011-09-07 EP disclosed
US-7820649-B2 Quinazolinone and isoquinolinone acetamide derivatives N.V. ORGANON (NL) 2010-10-26 US disclosed
US-20080090802-A1 QUINAZOLINONE AND ISOQUINOLINONE ACETAMIDE DERIVATIVES N.V. ORGANON (NL) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090802-A1 QUINAZOLINONE AND ISOQUINOLINONE ACETAMIDE DERIVATIVES NQO2, GATD3, SDHA USP25 3089/4885USP28 2997/4885IP6K1 2048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.